Tumor infiltrating lymphocyte (TILs) obtained from glioblastoma patient’s tumor specimens (n = 4) were evaluated for the presence of CD4+, CD8+, T reg (CD25+ FOXP3), and microglia (CD11b + CD45), through flow cytometry. This evidence concerns the gene CD4 and neoplasm.